AI x tissue-engineering lab FabioZB raises $20M, ex-DeepMind researcher joins as co-founder
vqctran · x · 2026-09-18
FabioZB announced a $20M round led by Quiet Capital with Gradient, Haystack and Compound participating. The team built an automated lab in New York spanning tissue engineering, stem cell biology and frontier AI, arguing reductionist single-cell approaches have plateaued in predictive validity. vqctran, a 10-year Google DeepMind veteran, joins as co-founder.
More from Venture
- Doctors wait up to a year to start: PE-backed staffing firm's Excel-bound credentialing process laid bare — alex_verem · 2026-11-02
- Ad creative automation startup Fastlane launches 2.0 with $3.5M seed round — Shruti_0810 · 2026-11-02
- Toby Walsh predicts market turbulence may force Anthropic to delay its late-2026 IPO — TobyWalsh · 2026-11-02
- Indie dev shuts down 6 zombie apps in one day to cut costs — CtrlAltDwayne · 2026-11-02
- US Black Friday online sales top $11.8B; Cyber Week hits $336.6B globally — ThePeterMick · 2026-11-02
- Alibaba Qwen exec sells AI token credits in Li Jiaqi's livestream targeting women — yangyi · 2026-11-02